Jehangir Khan

Biography

Dr. Jehangir K. Khan is the President of Preclinical Insight Ltd, a drug discovery and preclinical development consultancy company. Previously Dr. Khan worked as the Director of Biological Sciences & Pharmaceutical Development at NAEJA Pharmaceutical Inc. In this role, he was actively involved in early discovery Structure Activity Relationship and in different areas of preclinical development such as Drug Metabolism, Pharmacokinetics, Pharmacodynamics, Safety profiling, Preformulation and Bioanalysis. Prior to joining NAEJA, Dr. Khan was the Director of Preclinical Development at Synphar Laboratories Inc. ​Over the past two decades Dr. Khan has been part of Research teams in developing  a topical antifungal product currently in the market, several other products in high-risk cardiovascular disease in phase 3, areas of inflammation in phase 2, an anti MRSA topical product in phase 2. ​ Dr. Khan is a co-inventor of amidine substituted beta-lactam patent with a candidate compound AIC499, a novel resistance breaking antibiotic against a broad range of MDR Gram-Negative Bacteria and diazabicyclooctane beta-lactamase inhibitor patents with a candidate compound Nacubactam (RG-6080, FPI-1459, OP-0595) in clinical development. ​ Dr. Khan received B.S & M.S degree in Pharmacy from University of Dhaka, Bangladesh and a magna cum laude Doctorate degree from the Faculty of Pharmaceutical Sciences, University of Ghent, Belgium in the field neurotoxin related to neurodegenerative diseases. He has published over 35 articles in professional scientific journals with international circulation and co-inventor in several patents, presented his research findings to at least 20 international meetings, and previously served as a member of International Panel of Experts for evaluation of potential drug candidates for Investigational New Drugs Publications. ​ In addition to his career in pharmaceutical research Dr. Khan has co-founded Inspire Global Corp Inc, a group of companies involved in e-commerce marketplace business solutions

Research Interest

Pharmaceutical Sciences